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Response of Appetite and Appetite Regulating Hormones
to Acute Hypoxia
Morgan Busboom, Robert Shute, and Dustin Slivka
University of Nebraska at Omaha

Abstract
AIM: To determine the acute response of appetite and appetite regulating hormones after exposure to simulated altitude. METHODS:
Seven males and five females (height: 178.9 ¡ 2.3 cm; weight: 77.3 ¡ 7.2 kg; body fat: 18.4 ¡ 1.7%) participated in two, three-hour
trials in a hypoxic (5000 m) and normoxic (350 m) environment. Blood samples were collected prior to and immediately following three
hours of exposure for the measurement of leptin, adiponectin, and acylated ghrelin. Appetite, acute mountain sickness, heart rate, blood
oxygenation, tissue oxygenation, respiration rate, and whole body gases were also measured. RESULTS: Leptin was not different
between hypoxic (5.8 ¡ 1.8 ng ml21) and normoxic trials (6.2 ¡ 2.0 ng ml21; p 5 0.603). Adiponectin was not different between
hypoxic (9.0 ¡ 0.2 mg ml21) and normoxic trials (8.4 ¡ 0.7 mg ml21; p 5 0.216). Acylated ghrelin was not different between hypoxic
(15.0 ¡ 3.8 pg ml21) and normoxic trials (16.3 ¡ 4.6 pg ml21; p 5 0.285). Appetite scores were not different between trials (p . 0.05)
with the exception of fullness which was greater in the hypoxic condition (p 5 0.027). Heart rate and symptoms of acute mountain
sickness were higher while blood and tissue oxygenation were lower in the hypoxic trial (p , 0.05). No differences were noted in other
metabolic parameters (p . 0.05). CONCLUSION: Appetite and appetite regulating hormones are not affected by three hours of hypoxic
exposure, and thus some of these negative consequences of hypoxic exposure may not be evident with short exposure times.
Keywords:

leptin, adiponectin, ghrelin, altitude, oxygenation, extreme environments

Introduction
There is a decline in body mass in response to extended exposure to altitude or hypoxia (Benso et al., 2007; Hamad &
Travis, 2006; Rose et al., 1988; Westerterp & Kayser, 2006; Westerterp-Plantenga et al., 1999; Zaccaria, Ermolao,
Bonvicini, Travain, & Varnier, 2004). When ascending to a higher altitude, the barometric pressure exerted on oxygen is
decreased causing a decline in arterial oxygen saturation (Mazzeo, 2008). When the body cannot deliver an adequate supply
of oxygenated blood to target tissues due to high altitude, this causes a state of hypoxia. Many factors may contribute to
reductions in body mass at altitude, including appetite, exercise (Westerterp & Kayser, 2006), altered intestinal function,
and overall disruption of energy balance (Hamad & Travis, 2006; Tschöp & Morrison, 2001) resulting in changes to both
fat mass and muscle mass (Tschöp & Morrison, 2001).
Weight loss has been observed after ascending to a simulated altitude of 8848 m, where a reduction in energy intake was
a key component for the loss of body mass over 31 days (Westerterp-Plantenga et al., 1999). Similar results were found
during a 40-day stay in a hypobaric chamber simulating the altitude of Mount Everest. Subjects consumed fewer calories,
lost weight, and lost body fat even when palatable food was provided ad libitum throughout the confinement (Rose et al.,
1988). Therefore, hypoxic conditions independent of food availability may be at least partially responsible for the observed
weight loss (Rose et al., 1988; Westerterp-Plantenga et al., 1999). Furthermore, the reduction in energy intake may be
attributed to a loss of appetite. Indeed, subjects who ascend to high altitude (8848 m) note changes in the following aspects
of an appetite profile: ‘‘deviations in hunger, desire to eat, estimation of how much one could eat, satiety, and fullness’’
(Westerterp-Plantenga et al., 1999). Acute mountain sickness (AMS) may also play a role in loss of appetite due to the
associated nausea (Westerterp-Plantenga et al., 1999). However, it is unknown whether the loss of appetite occurs with
hypoxia alone or if other conditions (exercise, temperature, food availability, etc.) inherent to these study designs are the
major factors. Further monitoring in a controlled laboratory environment is needed to determine if hypoxia independently
drives the loss of appetite. Several hormones regulate appetite and changes in these hormones with exposure to hypoxia
may explain changes in appetite and body mass at altitude.
Leptin, adiponectin, and ghrelin work to regulate appetite and maintain energy homeostasis through receptors in the
hypothalamus and pituitary gland. Increased levels of leptin work to keep one satiated after eating (Zhang et al., 1994),
while decreased levels of adiponectin and ghrelin signal the hypothalamus that food intake is not necessary and energy
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balance has been met (Cummings, 2006; Kadowaki,
Yamauchi, & Kubota, 2008). Current research is unclear
in determining the effects of altitude exposure on leptin,
adiponectin, and ghrelin plasma concentrations. These hormones appear to respond quickly to metabolic alterations.
Leptin may decrease as early as 60 minutes following
exposure to a simulated altitude of 4300 m (Kelly et al.,
2010). During short-term exposures to hypoxia, ghrelin
and acylated ghrelin levels appear to decrease after
48 hours of free-living conditions (Shukla et al., 2005)
and after 7 hours of controlled environmental chamber
conditions (Shukla et al., 2005; Wasse, Sunderland, King,
Batterham, & Stensel, 2012). During extended exposures
to altitude, leptin concentrations may decrease, increase,
or remain unchanged during acute and chronic exposures
to altitude (Barnholt et al., 2006; Debevec, Simpson,
Macdonald, Eiken, & Mekjavic, 2014; Shukla et al., 2005;
Tschop et al., 2000; Zaccaria et al., 2004). Few studies have
investigated adiponectin’s acute response to altitude; however, there appears to be no change in adiponectin levels
after chronic exposure to free-living altitude (4300 m)
conditions (Barnholt et al., 2006).
The limited research describing the acute response (within a
few hours) of these hormones coupled with a lack of control
in many field-based investigations warrant further study.
Therefore, the purpose of this study is to determine the acute
response of appetite and appetite regulating hormones after
exposure to simulated altitude in well-controlled resting
conditions. It is important to investigate the connection
between appetite regulation and altitude exposure to understand if weight loss at increased altitude is attributed to
appetite suppression or other factors such as temperature and
exercise that tend to accompany exposure to hypoxia. This
knowledge may provide information on possible strategies
that could be incorporated early to help preserve body mass
for those mountaineering or a possible novel treatment for
overweight or obese individuals with increased appetite.
Materials and Methods
Participants
Twelve recreationally active (seven males and five females)
subjects were recruited for this study. Recreationally active
males and females were defined as anyone self-reporting
structured exercise 2–5 times weekly. After describing the
procedures and potential risks to the participants they were
asked to sign an Institutional Review Board approved
informed consent before participating.
Study Design
General overview
Subjects were exposed to normobaric hypoxia simulating 5000 m and ambient oxygen content (350 m) for

three hours. The altitude of 5000 m was chosen as it is
slightly higher than what has been used in previous studies
that have demonstrated an effect on appetite regulating hormones and represents the higher limit of the experimental
chamber capacity. Subjects were seated and rested during
the three-hour duration. Trials were separated by no more
than five days. Blood samples (4 mL) were collected from
the antecubital vein before and after exposure and analyzed
for the acute response in the key appetite regulating hormones, leptin, adiponectin, and acylated ghrelin. Perceived
appetite and symptoms of AMS were also assessed. Heart
rate, blood oxygenation, respiration rate, tissue oxygenation, and whole body gas exchange were analyzed throughout the trials.
Initial visit
Height, weight, and percent body fat were collected for
descriptive purposes. Percent body fat was measured using
an electronic load cell-based hydrostatic weighing system
(Exertech, Dresbach, MN). Each subject performed six
to ten trials, with the highest three underwater weights
averaged and recorded. Body density was calculated from
the underwater weight and was converted to percent body
fat using the Siri equation (Siri, 1961). Residual lung and
gastrointestinal volume was estimated and corrected
for using an established prediction equation (Thomas &
Etheridge, 1980).
Experimental trials
Experimental trials were conducted in a randomized and
counterbalanced order. The experimental trials for women
were completed between days 3 and 8 of the follicular
phase of the menstrual cycle (Kelly et al., 2010) to control
for fluctuations in leptin across the menstrual cycle (Lecke,
Morsch, & Spritzer, 2011). The menstrual cycle has no
effect on adiponectin or ghrelin concentrations (Dafopoulos,
Sourlas, Kallitsaris, Pournaras, & Messinis, 2009). Thus,
trials were separated by approximately five days. Men’s
experimental trials were also separated by five days for
consistency. Subjects were required to record a 24-hour
food log prior to the first experimental trial and repeat the
24-hour log before the second experimental trial. Subjects
were not allowed to exercise 24 hours prior to the experimental trials. The day prior to the experimental trials,
participants were provided with a small standardized breakfast and were instructed to eat the breakfast two hours before
arrival atthe laboratory. The standardized meal consisted of
a granola bar and orange juice (375 kcal, 75 g carbohydrates, 7 g fat, 6 g protein). All trials were conducted in
the morning to account for diurnal variation in hormones
(Bray & Young, 2007; Kotidis et al., 2006; Shetty, Kusminski,
& Scherer, 2009).
The experimental trials consisted of two separate, threehour, resting trials. One trial was conducted in a normobaric hypoxic condition (12.03% oxygen fraction simulating
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5000 m) and the other in an ambient control condition
(350 m). The trials were conducted in an environmental
chamber (Darwin, St Louis, MO) that controlled for
temperature (22 ˚ C), humidity (40%) and environmental
oxygen concentration simulating altitude (Altitude Control
Technologies, Lafayette, CO). Participants remained in a
seated position for the duration of the trials, except when
completing a clinical assessment of AMS (described in
detail below).
Blood collection
Blood samples were collected immediately prior to
entering the environmental chamber and immediately
following the three hours of altitude exposure. Approximately 4 mL of blood was collected using venipuncture
technique from the antecubital vein into an ethylenediaminetetraacetic acid-coated vacutainer (Greiner Bio-One, Monroe,
NC). Within three minutes of the collection of blood the
vacutainer was treated with 40 mL of HALT protease
inhibitor (Thermo Fisher, Wilmington, DE) and inverted
several times. Whole blood was transferred to two capillary
tubes and centrifuged for 5 minutes for analysis of hematocrit in duplicate (ZIPOcrit, LW Scientific, Lawrenceville,
GA). A separate whole blood sample was transferred to a
microcuvette and analyzed for hemoglobin (HemoCue,
Cypress, CA). The values of hematocrit and hemoglobin
were used to correct for plasma volume shifts that may
occur with altitude exposure (Miles, Bransford, & Horvath,
1981). The remaining blood samples were then centrifuged
for 10 minutes at 3500 rpm at 4 ˚ C and the plasma was
aliquoted into 200 mL volumes. The plasma samples were
then frozen at 230 ˚ C for later analysis of leptin, adiponectin, and acylated ghrelin.
Circulating leptin, ghrelin, and adiponectin
Concentrations of the hormones were determined in
triplicate using enzyme-linked immunosorbent assay (ELISA)
kits. Manufacturer’s protocols were followed for each leptin,
adiponectin, and acylated ghrelin ELISA kit (Bertin Pharma,
Montigny-le-Bretonneux, France). Plasma samples were
diluted 1:3, 1:30, and 1:2 for leptin, adiponectin, and
acylated ghrelin, respectively.
Appetite and mountain sickness
The Lake Louise Self-Report Questionnaire addressed
symptoms associated with AMS—headache, appetite and
nausea, fatigue, and lightheadedness (Roach, Bartsch,
Hackett, & Oelz, 1993). Along with subjective feelings
of the subject, clinical assessments related to AMS were
performed. Subjects were asked to perform a physical
task of tandem walking to assess ataxia or loss of full
control of bodily movements. Changes in mental status or
signs of peripheral edema were recorded. A combined score
. 5 was defined as clinically significant AMS (Bartsch
et al., 1993).

A 100 mm Visual Analogue Scale was used to assess
the subjects’ perceived appetite. The following questions
were used for the assessment as recommended by Blundell
et al. (2010): ‘‘how hungry are you?’’, ‘‘how full are you?’’,
‘‘how satiated are you?’’, ‘‘how strong is your desire to
eat?’’ and ‘‘how much do you think you could eat right
now?’’ A Composite Satiety Score (CSS) was also used
to assess appetite. The CSS was calculated as follows:
CSS 5 (fullness + (100 2 desire) + (100 2 hunger) +
(100 2 perceived food consumption (PFC)))/4 (Debevec
et al., 2014).
Heart rate, oxygen saturation, and metabolism
Heart rate (Polar V800; Polar, Lake Success, NY), blood
oxygenation (WristOx2; Nonin Medical, Inc., Plymouth,
MN), and tissue oxygenation (MOXY, Hutchinson, MN)
were monitored continuously throughout the trials. The
pulse oximeter was worn on each subject’s index finger.
Tissue oxygenation was measured using a near-infrared
spectroscopy device that was adhered to a subject’s skin
over the vastus lateralis. This non-invasive device allows
for continuous monitoring of tissue oxygenation throughout the trials. Heart rate, blood, and tissue oxygenation data
were averaged for 1, 2, and 3 hours. Metabolic gases and
respiration rate (TrueOne Metabolic System; ParvoMedics,
Sandy, Utah) were measured by requiring subjects to
breathe through a mouthpiece and wear a nose clip, while
expired air was collected and analyzed. Measurements
were collected in five-minute increments at 55-, 115-, and
175-minute time points. Carbohydrate oxidation (%) and
fat oxidation (%) were calculated by a TrueOne Metabolic System using equations derived from Peronnet and
Massicote (1991).
Statistical Analysis
A repeated measures two-way ANOVA (2 6 2, time by
trial) was used to determine statistical significance. After
running the ANOVA, if significance was found a Fisher’s
protected least significant difference post hoc test was used
to determine where significance occurred. Significance was
set at 5% error rate (p , 0.05). Statistical Package for
Social Sciences software (SPSS 23.0, Chicago, IL) was
used to analyze data.
Results
Participants
Twelve participants (24.6 ¡ 0.7 years, body mass of
77.3 ¡ 7.2 kg, 178.9 ¡ 2.3 cm, 18.4 ¡ 1.7%), namely
seven males (25.1 ¡ 1.1 years, 83.0 ¡ 8.1 kg, 179.3 ¡
2.0 cm, 15.3 ¡ 2.1%) and five females (23.8 ¡ 0.4 years,
69.3 ¡ 8.2 kg, 178.4 ¡ 5.2 cm, 22.6 ¡ 1.1%), completed
the study. Eleven subjects’ blood was analyzed due to
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Figure 1. (n 5 12) Hunger scores (A), fullness scores (B), satiety scores (C), desire scores (D), PFC scores (E), and CSS (F); *p , 0.05 from normoxic,
{
p , 0.05 from 1 h, {p , 0.05 from 2 h, #p , 0.05 from 1 h normoxic, ##p , 0.05 from 2 h hypoxic. Data are mean ¡ SE.

inability to obtain post-experimental trial blood from one
female subject.
Appetite
No differences occurred between trials for the following
appetite scores: hunger (p 5 0.094), satiety (p 5 0.507),
desire (p 5 0.139), or perceived food consumption (p 5
0.390). However, fullness was higher in the hypoxic
condition compared to the normoxic condition (p 5 0.027).
Hunger, desire, and perceived food consumption increased
from 1 h to 2 h (p , 0.001, p 5 0.001, p 5 0.009, respectively) and continued to increase from 2 h to 3 h
(p 5 0.001, p 5 0.001, p , 0.001, respectively). Satiety
decreased from 1 h to 2 h (p 5 0.036) and continued to
decrease from 2 h to 3 h (p 5 0.016), regardless of trial.
Fullness decreased from 1 h to 3 h (p 5 0.005) and from
2 h to 3 h (p 5 0.003), regardless of trial. CSS decreased
from 1 h to 2 h (p 5 0.002) and then continued to decrease
from 2 h to 3 h (p 5 0.001; Figure 1), regardless of trial.
Appetite Regulating Hormone Plasma Concentrations
Based on hemoglobin and hematocrit measures, plasma
volume increased 1.9 ¡ 1.5% for the hypoxic trials and

3.3 ¡ 1.4% for the normoxic trials. Hormone concentrations
were adjusted to account for this change. There were no
differences between the hypoxic and normoxic trials in the
appetite regulating hormones leptin (p 5 0.603), adiponectin (p 5 0.216), or acylated ghrelin (p 5 0.285). No
differences were observed pre- to post-trial for leptin
(p 5 0.060), adiponectin (p 5 0.866), or acylated ghrelin
(p 5 0.481; Figure 2).
Acute Mountain Sickness
AMS scores were higher in the hypoxic condition (0.66
¡ 0.91 points) than in the normoxic condition (0.07 ¡
0.18 points; p 5 0.021). No single subject had a clinically
significant score of AMS, defined as having a score . 5.
Blood and Tissue Oxygenation
Blood oxygenation was lower in the hypoxic condition
compared to the normoxic condition (p 5 0.001) regardless
of time (p 5 0.196). Tissue oxygenation was lower in the
hypoxic condition compared to the normoxic condition
(p 5 0.011). Tissue oxygenation increased from 1 h to 2 h
(p 5 0.042) and then continued to increase from 2 h to 3 h
(p 5 0.006; Table 1), regardless of trial.
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Figure 2. (n 5 11) Plasma leptin concentrations (A), plasma adiponectin concentrations (B), and plasma acylated ghrelin concentrations (C).
Data are mean ¡ SE.
Table 1
(n 5 12) Study parameters measured during experimental trials.

Heart rate (bpm)
Normoxic
Hypoxic

Hour 1

Hour 2

Hour 3

Grand mean

75¡3
80¡3

68¡3{
76¡3{

67¡3
76¡3

70¡2
78¡1*

% CHO utilization (p 5 0.281), or % fat utilization (p 5
0.280). However, % CHO oxidation decreased from 1 h to
3 h (p 5 0.004) and 2 h to 3 h (p 5 0.025) while fat
oxidation increased from 1 h to 3 h (p 5 0.004) and from
2 h to 3 h (p 5 0.025; Table 1), regardless of trial.
Heart Rate

Blood oxygenation
(%)
Normoxic
Hypoxic

97¡0.4
80¡1

98¡0.5
79¡1

98¡0.3
81¡1

98¡0.3
80¡0.5*

Tissue oxygenation
(%)
Normoxic
Hypoxic

59¡3
55¡3

63¡3{
55¡3{

67¡3{{
58¡4{{

63¡2
56¡1*

VO2 (L min21)
Normoxic
Hypoxic

0.32¡0.02 0.32¡0.02
0.32¡0.03 0.36¡0.05

0.33¡0.02 0.32¡0.01
0.36¡0.05 0.35¡0.01

Respiratory rate
(bpm)
Normoxic
Hypoxic

15.4¡0.7
14.6¡0.9

15.4¡0.7
14.8¡0.8

15.5¡0.9
15.1¡1

15.4¡0.0
14.8¡0.2

Carbohydrates (%)
Normoxic
Hypoxic

42¡8
57¡15

35¡10
48¡19

17¡10{{
41¡19{{

31¡7
49¡4

Fat (%)
Normoxic
Hypoxic

59¡8
44¡15

66¡10
53¡19

83¡10{{
59¡19{{

69¡7
52¡4

Note. Data are mean ¡ SE.
*p , 0.05 from normoxic; {p , 0.05 from 1 h; {p , 0.05 from 2 h.

Oxygen Utilization and Substrate Use
No differences occurred between hypoxic and normoxic
trials in absolute VO2 (p 5 0.606), respiratory rate (p 5 0.318),

Heart rate was higher in the hypoxic condition compared
to the normoxic condition (p 5 0.001). Heart rate decreased
from 1 h to 2 h (p 5 0.004), but remained similar between
2 h and 3 h (p 5 0.464; Table 1), regardless of trial.
Discussion
This study aimed to determine the effect of acute hypoxic
exposure on appetite and appetite regulating hormones.
Although research is limited with acute exposure to
hypoxia, it was hypothesized that leptin would be higher,
and adiponectin and acylated ghrelin would be lower,
resulting in lower appetite in hypoxia compared to normoxia.
The main findings of this study were that there were no
differences in appetite regulating hormones between hypoxia and normoxia in our subjects. Only the feeling of fullness was marginally lower in hypoxia compared to normoxia,
but other aspects of appetite were not different between
hypoxia and normoxia.
Previous research has focused primarily on extended
stays in a hypoxic environment with little information
regarding the acute response. The current study is one of
very few to investigate the effects of acute exposure to
hypoxia on appetite and appetite regulating hormones.
When this body of literature is taken collectively, differences in appetite regulating hormones associated with
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hypoxia may be related to longer durations than what was
used in the current study. Reductions in body mass were
observed along with increased leptin and decreased ghrelin
resulting in a loss of appetite after seven days at 4300 m in
free-living conditions (Shukla et al., 2005). Few human
studies have investigated adiponectin in this context, but
during free-living altitude (4300 m) exposure for three
weeks, no changes in adiponectin levels were observed
(Barnholt et al., 2006). Shorter exposures to hypoxia may
also elicit changes. Leptin concentrations increased after
20 hours of being transported to an elevation of 4559 m.
This increase was also accompanied by a loss of appetite
(Tschop et al., 2000). However, appetite and hormones
do not always have a strong agreement (Wasse et al., 2012).
In contrast to that study and the current study, an acute stay
in a well-controlled normobaric hypoxic chamber (simulating 4300 m) found leptin concentrations to decrease as
opposed to increase within 60 minutes of hypoxic exposure
after carbohydrate supplementation (Kelly et al., 2010).
After seven hours in a normobaric hypoxic chamber, acylated
ghrelin was found to decrease, potentially indicating the
subjects were not as hungry (Wasse et al., 2012). The
current study did not observe any differences in leptin,
adiponectin, or acylated ghrelin. Thus, three hours of
exposure to hypoxia may not be sufficient time to elicit
meaningful changes in appetite or appetite regulating
hormones. Furthermore, appetite regulation is likely much
more complex than regulation by these three hormones
alone (Kalra et al., 1999; Suzuki, Simpson, Minnion, Shillito,
& Bloom, 2010).
An alternative interpretation of our results is that these
hormones do not respond within three hours despite a
sufficient stimulus. It is possible that these hormones did
respond to the hypoxic stimuli but are not observable until
some time in the future. This study did not look at these
response kinetics, but these hormones do respond quickly
with other stimuli. High-intensity exercise with durations as
short as 20 minutes (Jürimäe, Purge, & Jürimäe, 2005), one
hour (Broom, Stensel, Bishop, Burns, & Miyashita, 2007),
and two hours (Duclos, Corcuff, Ruffie, Roger, & Manier,
1999) have shown changes in these hormone concentrations compared to resting values demonstrating the rapidity
of response that these hormones have. Exercise results in
shifts in substrate use from fat oxidation to more carbohydrate oxidation. Similar to exercise, hypoxic exposure
can cause a similar shift in metabolism. Specifically, leptin
is affected by these shifts in metabolism (Tuominen et al.,
1997). When subjects were fed carbohydrate before acute
exposure to hypoxia, not only did substrate use shift but
leptin was also altered compared to a normoxic control
(Kelly et al., 2010). Indeed, further research supports the
regulation of blood glucose by leptin. Refer to the review
by Morton and Schwartz (2011) for a detailed discussion
on the role of leptin in glucose metabolism. Thus, an
alteration in substrate use, metabolism, or blood glucose

may be a result of circulating leptin as opposed to an
outcome. The current study did not see a significant
difference in leptin and therefore explain why substrate use,
oxygen utilization, or respiratory rate were not altered.
Additionally, high blood glucose by intravenous glucose
infusion does not appear to affect appetite-related outcomes
(Schultes et al., 2016). The current study did not directly
measure blood glucose. However, the lack of difference in
substrate use between trials would suggest that blood
glucose was also not different. Perhaps longer or more
extreme hypoxia would cause a change in leptin and be
accompanied by a shift in metabolism or alteration in blood
glucose.
An additional difference besides time course and metabolic alterations between the current study and those that
found differences in leptin and ghrelin with hypoxic exposure is that many previous studies have been conducted in
free-living conditions such as mountaineering expositions that do not allow specific control. The current study
was conducted in a well-controlled normobaric hypoxia
chamber. There has been some debate on the potential differences in physiological responses between normobaric
and hypobaric hypoxia exposure (Coppel, Hennis, GilbertKawai, & Grocott, 2015). AMS scores tend to be higher
in hypobaric hypoxia compared to normobaric hypoxia
(Loeppky et al., 2005; Roach, Loeppky, & Icenogle, 1996).
Ventilation is also lower in hypobaric compared to normobaric hypoxia (Roach et al., 1996). We did not observe
measurable AMS or alterations in respiratory rate, which
may be related to incorporating a normobaric vs. hypobaric
intervention. Higher AMS during hypobaric hypoxia may
in part lead to a decrease in appetite during exposure.
Aspects of nausea associated with hypobaric hypoxia may
help explain decreased appetite and weight loss at extended
stays in hypoxia. Despite these potential differences, we did
observe a hypoxic response, decreased blood and tissue
oxygenation, and increased heart rate. Research using
mountaineering or free-living designs is also unable to
control for factors such as temperature, exercise, and diet,
which may influence hormone concentrations. Cold exposure and exercise are associated with decreases in leptin
(Peino et al., 2000; Sierra-Johnson, Romero-Corral, Somers,
& Johnson, 2008). Aerobic activity is associated with
decreases in acylated ghrelin (Broom, Batterham, King,
& Stensel, 2009). Longer term exercise training programs are related to changes in body mass, which may be
responsible for deceases in leptin and increases in
adiponectin (Fatouros et al., 2005). Not controlling for
diet in free-living designs may also result in changes in
hormones that are not specifically related to hypoxia
(Sierra-Johnson et al., 2008). The current study controlled for temperature and exercise by conducting the
experimental trials in an environmental chamber where
subjects were seated at room temperature (22 ˚ C) throughout the three hours.
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Conclusion
In conclusion, the current study indicates that appetite
and appetite regulating hormones are not affected by three
hours of hypoxic exposure. This finding has important
implications for individuals who may be exposed to short
periods of hypoxia. During these short periods, the negative
consequences associated with hypoxia such as a loss of
appetite and body mass do not appear to be evident. Longer
durations or more intense hypoxia may be required in order
to see differences in appetite, appetite regulating hormones,
and overall energy imbalances—which may lead to decreases
in body mass (Hamad & Travis, 2006; Tschöp & Morrison,
2001; Westerterp & Kayser, 2006). When the current
study is interpreted along with previous research it
contributes to the understanding of the time course of
responses associated with hypoxia and may be considered in interventions designed to counter the negative
outcomes associated with hypoxia.
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